Demographics for all patients with echocardiographic evidence of PHT
| All PHT (n=936) | PAH (n=25) | PLHD (n=636) | RPHT (n=87) | CTEPH (n=19) | Misc (n=25) | UPHT (n=144) | |
| Age, years* | 75±12.5 | 62±13.21 | 79±13.21 | 75±9.08 | 77±9.26 | 74±12.41 | 79±12.47 |
| Female, %† | 60 | 64 | 52 | 49 | 74 | 56 | 65 |
| BMI (±SD) | 27.5±15.8 | 28.21±5.06 | 27.32±9.02 | 26.86±8.84 | 31.44±6.56 | 27.99±12.01 | 27.60±8.69 |
| ePASP mm Hg‡ (all PHT mean ±SD, subgroups medians and IQR) | 56±11.3 | 60 (34) | 52 (12) | 55 (22) | 57 (20) | 53 (16) | 52 (12) |
Statistical significance differences between *median age (p<0.001), †female % (p=0.03) for PHT, PAH, PLHD, RPHT, CTEPH, Misc, UPHT, ‡median ePASP (estimated pulmonary artery systolic pressure) (p=0.0023).
CTEPH, chronic thromboembolic pulmonary hypertension; Misc PHT, miscellaneous pulmonary hypertension; PAH, pulmonary arterial hypertension; PLHD, pulmonary hypertension secondary to left heart disease; RPHT, respiratory-associated pulmonary hypertension; UPHT, pulmonary hypertensions of unknown cause.